Search research articles
Contact Us
Filters
Showing results (331-340 of 385) with videos related to
Page
of 39
Sort By:
European Journal of Heart Failure
|
August 6, 2025
Clinical and echocardiographic phenotype of cardiac wasting in patients with advanced cancer
Markus S Anker, Muhammad Shahzeb Khan, Anja Nikolski, et al.
Trials
|
October 7, 2020
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial
Maike Janssen, Ulrike Schäkel, Carine Djuka Fokou, et al.
Leukemia
|
May 26, 2022
The bone marrow niche regulates redox and energy balance in MLL::AF9 leukemia stem cells
Ana C Viñado, Isabel A Calvo, Itziar Cenzano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2023
Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes
Daniel Noerenberg, Franziska Briest, Cornelius Hennch, et al.
Blood Advances
|
September 30, 2024
Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurin
Frank G Rücker, Lars Bullinger, Sibylle Cocciardi, et al.
Blood Advances
|
April 29, 2022
Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications
Hartmut Döhner, Daniela Weber, Julia Krzykalla, et al.
Blood
|
May 2, 2013
Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG)
Verena I Gaidzik, Richard F Schlenk, Peter Paschka, et al.
Nature
|
November 17, 2017
BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation
Simon Raffel, Mattia Falcone, Niclas Kneisel, et al.
Blood
|
March 22, 2014
Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial
Stephan Stilgenbauer, Andrea Schnaiter, Peter Paschka, et al.
Blood
|
September 8, 2018
Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML
Felicitas Thol, Razif Gabdoulline, Alessandro Liebich, et al.
Page
of 39
Search research articles
Search
Showing results (331-340 of 385) with videos related to
Sort By:
Page
of 39
European Journal of Heart Failure
|
August 6, 2025
Clinical and echocardiographic phenotype of cardiac wasting in patients with advanced cancer
Markus S Anker, Muhammad Shahzeb Khan, Anja Nikolski, et al.
Trials
|
October 7, 2020
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial
Maike Janssen, Ulrike Schäkel, Carine Djuka Fokou, et al.
Leukemia
|
May 26, 2022
The bone marrow niche regulates redox and energy balance in MLL::AF9 leukemia stem cells
Ana C Viñado, Isabel A Calvo, Itziar Cenzano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2023
Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes
Daniel Noerenberg, Franziska Briest, Cornelius Hennch, et al.
Blood Advances
|
September 30, 2024
Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurin
Frank G Rücker, Lars Bullinger, Sibylle Cocciardi, et al.
Blood Advances
|
April 29, 2022
Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications
Hartmut Döhner, Daniela Weber, Julia Krzykalla, et al.
Blood
|
May 2, 2013
Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG)
Verena I Gaidzik, Richard F Schlenk, Peter Paschka, et al.
Nature
|
November 17, 2017
BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation
Simon Raffel, Mattia Falcone, Niclas Kneisel, et al.
Blood
|
March 22, 2014
Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial
Stephan Stilgenbauer, Andrea Schnaiter, Peter Paschka, et al.
Blood
|
September 8, 2018
Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML
Felicitas Thol, Razif Gabdoulline, Alessandro Liebich, et al.
Page
of 39